Drawing for MIRISK

USPTO serial 97315103

MIRISK

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
NUNLEY, CHRISTOPHER MICHAEL
Law office
TTAB

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 604: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with MIRISK?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

MARGARET C. MCHUGH

MARGARET C. MCHUGH KILPATRICK TOWNSEND & STOCKTON LLPTWO EMBARCADERO CENTERSUITE 1900SAN FRANCISCO, CA 94111

Goods and services

ClassDescriptionStatusFirst use
001Chemicals for use in industry and science; reagents for use in industry and science; test and collection kits containing chemicals for use in industry and science; sampling kits containing chemicals for use in industry and science; diagnostic kits containing chemicals for use in industry and scienceABANDONED—
005Diagnostic preparations for medical use; diagnostic preparations for medical use and pharmaceutical research use; diagnostic preparations for medical purposes; sampling kits containing preparations for medical or pharmaceutical purposes use, namely, chemical reagents for sampling bodily fluids and tissue; test kits consisting of chemical reagents for medical purposes; kits consisting of chemical reagents for medical purposesABANDONED—
042Scientific and technological services, namely, scientific research, analysis, and testing in the field of disease diagnosis; scientific analysis and research services in the medical, biotechnological and equipment diagnostic fields; industrial analysis and research services in the medical, biotechnological and equipment diagnostic fields; research and related development of pharmaceutical products and substances; development of new medicines; scientific research services for diagnostic purposes; scientific research, namely, preparing scientific opinions; scientific research consulting; contract research in the field of pharmacological and clinical development of medicinal products; medical research services, namely, analysis of data and clinical trialsABANDONED—
044Medical and veterinary services; health care for humans and animals; medical and veterinary diagnostic testing, monitoring and reporting services in pre-clinical and clinical areas; medical and veterinary diagnostic testing, monitoring and reporting services for humans and animals; services of a medical diagnostic laboratory, namely, analysis, detection and identification of components in bodily samples and tissue; medical analysis services relating to the treatment of humans and animals; medical diagnostic services for determining diseases or disorders, monitoring diseases or disorders, and determining the therapeutic success of diseases or disorders; non-invasive medical diagnostic testing, monitoring and reporting services; blood and biopsy-based medical diagnostic testing, monitoring and reporting services; personalized medical diagnostic testing, monitoring and reporting services; medical services, namely, diagnostic health monitoring and health surveillanceABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 16, 2026MAB4ABANDONMENT NOTICE E-MAILED - INTER PARTES DECISION—
Sep 16, 2026ABN4ABANDONMENT - AFTER INTER PARTES DECISION—
Sep 16, 2026OP.TOPPOSITION TERMINATED NO. 999999—
Sep 16, 2026OP.SOPPOSITION SUSTAINED NO. 999999—
May 27, 2026ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED—
May 27, 2026OP.IOPPOSITION INSTITUTED NO. 999999—
Feb 11, 2026ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Jan 27, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 27, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 21, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 2, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 18, 2025XAECEXAMINER'S AMENDMENT ENTERED—
Dec 18, 2025GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Dec 18, 2025GNEAEXAMINERS AMENDMENT E-MAILED—
Dec 18, 2025CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 12, 2025GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Dec 12, 2025GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Dec 12, 2025CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
May 30, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 30, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 30, 2024ALIEASSIGNED TO LIE—
Dec 27, 2023ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Dec 7, 2023GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Dec 7, 2023GNSLLETTER OF SUSPENSION E-MAILED—
Dec 7, 2023CNSLSUSPENSION LETTER WRITTEN—
Mar 1, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 28, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 28, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 2, 2022GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 2, 2022GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 2, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 25, 2022DOCKASSIGNED TO EXAMINER—
Mar 23, 2022MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Mar 22, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 19, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance